Meredith G Harris1,2, Alan E Kazdin3, Wai Tat Chiu4, Nancy A Sampson4, Sergio Aguilar-Gaxiola5, Ali Al-Hamzawi6, Jordi Alonso7,8,9, Yasmin Altwaijri10, Laura Helena Andrade11, Graça Cardoso12, Alfredo Cía13, Silvia Florescu14, Oye Gureje15, Chiyi Hu16, Elie G Karam17,18,19, Georges Karam17,18,19, Zeina Mneimneh20, Fernando Navarro-Mateu21, Bibilola D Oladeji15, Siobhan O'Neill22, Kate Scott23, Tim Slade24, Yolanda Torres25, Daniel Vigo26,27, Bogdan Wojtyniak28, Zahari Zarkov29, Yuval Ziv30, Ronald C Kessler4. 1. The University of Queensland School of Public Health, Herston, Queensland, Australia. 2. Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Queensland, Australia. 3. Department of Psychology, Yale University, New Haven, Connecticut. 4. Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts. 5. Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California. 6. Al-Qadisiya University College of Medicine, Diwaniya Governorate, Iraq. 7. IMIM-Hospital del Mar Research Institute, Parc de Salut Mar, Barcelona, Spain. 8. Departament de Ciències Experimentals i de la Salut, Pompeu Fabra University, Barcelona, Spain. 9. CIBER en Epidemiología y Salud Pública, Barcelona, Spain. 10. Epidemiology Section, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. 11. Núcleo de Epidemiologia Psiquiátrica (LIM 23), Instituto de Psiquiatria Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. 12. Lisbon Institute of Global Mental Health and Chronic Diseases Research Center, NOVA Medical School, NOVA University of Lisbon, Lisbon, Portugal. 13. Anxiety Disorders Center, Buenos Aires, Argentina. 14. National School of Public Health, Management and Development, Bucharest, Romania. 15. Department of Psychiatry, University College Hospital, Ibadan, Nigeria. 16. Shenzhen Institute of Mental Health, Shenzhen Kangning Hospital, Shenzhen, China. 17. Department of Psychiatry and Clinical Psychology, Faculty of Medicine, Balamand University, Beirut, Lebanon. 18. Department of Psychiatry and Clinical Psychology, St George Hospital University Medical Center, Beirut, Lebanon. 19. Institute for Development Research Advocacy and Applied Care, Beirut, Lebanon. 20. Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor. 21. UDIF-SM, Subdirección General de Planificación, Innovación y Cronicidad, Servicio Murciano de Salud, IMIB-Arrixaca, CIBERESP-Murcia, Murcia, Spain. 22. Ulster University School of Psychology, Londonderry, United Kingdom. 23. Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand. 24. The Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, New South Wales, Australia. 25. Center for Excellence on Research in Mental Health, CES University, Medellín, Colombia. 26. Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada. 27. Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts. 28. National Institute of Public Health-National Institute of Hygiene, Warsaw, Poland. 29. National Center of Public Health and Analyses, Directorate of Mental Health and Prevention of Addictions, Sofia, Bulgaria. 30. Mental Health Services, Israeli Ministry of Health, Jerusalem, Israel.
Abstract
Importance: The perceived helpfulness of treatment is an important patient-centered measure that is a joint function of whether treatment professionals are perceived as helpful and whether patients persist in help-seeking after previous unhelpful treatments. Objective: To examine the prevalence and factors associated with the 2 main components of perceived helpfulness of treatment in a representative sample of individuals with a lifetime history of DSM-IV major depressive disorder (MDD). Design, Setting, and Participants: This study examined the results of a coordinated series of community epidemiologic surveys of noninstitutionalized adults using the World Health Organization World Mental Health surveys. Seventeen surveys were conducted in 16 countries (8 surveys in high-income countries and 9 in low- and middle-income countries). The dates of data collection ranged from 2002 to 2003 (Lebanon) to 2016 to 2017 (Bulgaria). Participants included those with a lifetime history of treated MDD. Data analyses were conducted from April 2019 to January 2020. Data on socioeconomic characteristics, lifetime comorbid conditions (eg, anxiety and substance use disorders), treatment type, treatment timing, and country income level were collected. Main Outcomes and Measures: Conditional probabilities of helpful treatment after seeing between 1 and 5 professionals; persistence in help-seeking after between 1 and 4 unhelpful treatments; and ever obtaining helpful treatment regardless of number of professionals seen. Results: Survey response rates ranged from 50.4% (Poland) to 97.2% (Medellín, Columbia), with a pooled response rate of 68.3% (n = 117 616) across surveys. Mean (SE) age at first depression treatment was 34.8 (0.3) years, and 69.4% were female. Of 2726 people with a lifetime history of treatment of MDD, the cumulative probability (SE) of all respondents pooled across countries of helpful treatment after seeing up to 10 professionals was 93.9% (1.2%), but only 21.5% (3.2%) of patients persisted that long (ie, beyond 9 unhelpful treatments), resulting in 68.2% (1.1%) of patients ever receiving treatment that they perceived as helpful. The probability of perceiving treatment as helpful increased in association with 4 factors: older age at initiating treatment (adjusted odds ratio [AOR], 1.02; 95% CI, 1.01-1.03), higher educational level (low: AOR, 0.48; 95% CI, 0.33-0.70; low-average: AOR, 0.62; 95% CI, 0.44-0.89; high average: AOR, 0.67; 95% CI, 0.49-0.91 vs high educational level), shorter delay in initiating treatment after first onset (AOR, 0.98; 95% CI, 0.97-0.99), and medication received from a mental health specialist (AOR, 2.91; 95% CI, 2.04-4.15). Decomposition analysis showed that the first 2 of these 4 factors were associated with only the conditional probability of an individual treatment professional being perceived as helpful (age at first depression treatment: AOR, 1.02; 95% CI, 1.01-1.02; educational level: low: AOR, 0.48; 95% CI, 0.33-0.70; low-average: AOR, 0.62; 95% CI, 0.44-0.89; high-average: AOR, 0.67; 95% CI, 0.49-0.91 vs high educational level), whereas the latter 2 factors were associated with only persistence (treatment delay: AOR, 0.98; 95% CI, 0.97-0.99; treatment type: AOR, 3.43; 95% CI, 2.51-4.70). Conclusions and Relevance: The probability that patients with MDD obtain treatment that they consider helpful might increase, perhaps markedly, if they persisted in help-seeking after unhelpful treatments with up to 9 prior professionals.
Importance: The perceived helpfulness of treatment is an important patient-centered measure that is a joint function of whether treatment professionals are perceived as helpful and whether patients persist in help-seeking after previous unhelpful treatments. Objective: To examine the prevalence and factors associated with the 2 main components of perceived helpfulness of treatment in a representative sample of individuals with a lifetime history of DSM-IV major depressive disorder (MDD). Design, Setting, and Participants: This study examined the results of a coordinated series of community epidemiologic surveys of noninstitutionalized adults using the World Health Organization World Mental Health surveys. Seventeen surveys were conducted in 16 countries (8 surveys in high-income countries and 9 in low- and middle-income countries). The dates of data collection ranged from 2002 to 2003 (Lebanon) to 2016 to 2017 (Bulgaria). Participants included those with a lifetime history of treated MDD. Data analyses were conducted from April 2019 to January 2020. Data on socioeconomic characteristics, lifetime comorbid conditions (eg, anxiety and substance use disorders), treatment type, treatment timing, and country income level were collected. Main Outcomes and Measures: Conditional probabilities of helpful treatment after seeing between 1 and 5 professionals; persistence in help-seeking after between 1 and 4 unhelpful treatments; and ever obtaining helpful treatment regardless of number of professionals seen. Results: Survey response rates ranged from 50.4% (Poland) to 97.2% (Medellín, Columbia), with a pooled response rate of 68.3% (n = 117 616) across surveys. Mean (SE) age at first depression treatment was 34.8 (0.3) years, and 69.4% were female. Of 2726 people with a lifetime history of treatment of MDD, the cumulative probability (SE) of all respondents pooled across countries of helpful treatment after seeing up to 10 professionals was 93.9% (1.2%), but only 21.5% (3.2%) of patients persisted that long (ie, beyond 9 unhelpful treatments), resulting in 68.2% (1.1%) of patients ever receiving treatment that they perceived as helpful. The probability of perceiving treatment as helpful increased in association with 4 factors: older age at initiating treatment (adjusted odds ratio [AOR], 1.02; 95% CI, 1.01-1.03), higher educational level (low: AOR, 0.48; 95% CI, 0.33-0.70; low-average: AOR, 0.62; 95% CI, 0.44-0.89; high average: AOR, 0.67; 95% CI, 0.49-0.91 vs high educational level), shorter delay in initiating treatment after first onset (AOR, 0.98; 95% CI, 0.97-0.99), and medication received from a mental health specialist (AOR, 2.91; 95% CI, 2.04-4.15). Decomposition analysis showed that the first 2 of these 4 factors were associated with only the conditional probability of an individual treatment professional being perceived as helpful (age at first depression treatment: AOR, 1.02; 95% CI, 1.01-1.02; educational level: low: AOR, 0.48; 95% CI, 0.33-0.70; low-average: AOR, 0.62; 95% CI, 0.44-0.89; high-average: AOR, 0.67; 95% CI, 0.49-0.91 vs high educational level), whereas the latter 2 factors were associated with only persistence (treatment delay: AOR, 0.98; 95% CI, 0.97-0.99; treatment type: AOR, 3.43; 95% CI, 2.51-4.70). Conclusions and Relevance: The probability that patients with MDD obtain treatment that they consider helpful might increase, perhaps markedly, if they persisted in help-seeking after unhelpful treatments with up to 9 prior professionals.
Authors: Björn Meyer; Paul A Pilkonis; Janice L Krupnick; Matthew K Egan; Samuel J Simmens; Stuart M Sotsky Journal: J Consult Clin Psychol Date: 2002-08
Authors: Ronny Bruffaerts; Meredith G Harris; Alan E Kazdin; Daniel V Vigo; Nancy A Sampson; Wai Tat Chiu; Ali Al-Hamzawi; Jordi Alonso; Yasmin A Altwaijri; Laura Andrade; Corina Benjet; Giovanni de Girolamo; Silvia Florescu; Josep Maria Haro; Chi-Yi Hu; Aimee Karam; Elie G Karam; Viviane Kovess-Masfety; Sing Lee; John J McGrath; Fernando Navarro-Mateu; Daisuke Nishi; Siobhan O'Neill; José Posada-Villa; Kate M Scott; Margreet Ten Have; Yolanda Torres; Bogdan Wojtyniak; Miguel Xavier; Zahari Zarkov; Ronald C Kessler Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2022-03-09 Impact factor: 4.519
Authors: Ronald C Kessler; Alan E Kazdin; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Yasmin A Altwaijri; Laura H Andrade; Corina Benjet; Chrianna Bharat; Guilherme Borges; Ronny Bruffaerts; Brendan Bunting; José Miguel Caldas de Almeida; Graça Cardoso; Wai Tat Chiu; Alfredo Cía; Marius Ciutan; Louisa Degenhardt; Giovanni de Girolamo; Peter de Jonge; Ymkje Anna de Vries; Silvia Florescu; Oye Gureje; Josep Maria Haro; Meredith G Harris; Chiyi Hu; Aimee N Karam; Elie G Karam; Georges Karam; Norito Kawakami; Andrzej Kiejna; Viviane Kovess-Masfety; Sing Lee; Victor Makanjuola; John J McGrath; Maria Elena Medina-Mora; Jacek Moskalewicz; Fernando Navarro-Mateu; Andrew A Nierenberg; Daisuke Nishi; Akin Ojagbemi; Bibilola D Oladeji; Siobhan O'Neill; José Posada-Villa; Victor Puac-Polanco; Charlene Rapsey; Ayelet Meron Ruscio; Nancy A Sampson; Kate M Scott; Tim Slade; Juan Carlos Stagnaro; Dan J Stein; Hisateru Tachimori; Margreet Ten Have; Yolanda Torres; Maria Carmen Viana; Daniel V Vigo; David R Williams; Bogdan Wojtyniak; Miguel Xavier; Zahari Zarkov; Hannah N Ziobrowski Journal: World Psychiatry Date: 2022-06 Impact factor: 79.683
Authors: Ymkje Anna de Vries; Meredith G Harris; Daniel Vigo; Wai Tat Chiu; Nancy A Sampson; Ali Al-Hamzawi; Jordi Alonso; Laura H Andrade; Corina Benjet; Ronny Bruffaerts; Brendan Bunting; José Miguel Caldas de Almeida; Giovanni de Girolamo; Silvia Florescu; Oye Gureje; Josep Maria Haro; Chiyi Hu; Elie G Karam; Norito Kawakami; Viviane Kovess-Masfety; Sing Lee; Jacek Moskalewicz; Fernando Navarro-Mateu; Akin Ojagbemi; José Posada-Villa; Kate Scott; Yolanda Torres; Zahari Zarkov; Andrew Nierenberg; Ronald C Kessler; Peter de Jonge Journal: J Affect Disord Date: 2021-04-20 Impact factor: 6.533
Authors: Andrew A Nierenberg; Meredith G Harris; Alan E Kazdin; Victor Puac-Polanco; Nancy Sampson; Daniel V Vigo; Wai Tat Chiu; Hannah N Ziobrowski; Jordi Alonso; Yasmin Altwaijri; Guilherme Borges; Brendan Bunting; José Miguel Caldas-de-Almeida; Josep Maria Haro; Chi-Yi Hu; Andrzej Kiejna; Sing Lee; John J McGrath; Fernando Navarro-Mateu; José Posada-Villa; Kate M Scott; Juan C Stagnaro; Maria C Viana; Ronald C Kessler Journal: Bipolar Disord Date: 2021-03-28 Impact factor: 5.345
Authors: Meredith G Harris; Alan E Kazdin; Richard J Munthali; Daniel V Vigo; Irving Hwang; Nancy A Sampson; Ali Al-Hamzawi; Jordi Alonso; Laura Helena Andrade; Guilherme Borges; Brendan Bunting; Silvia Florescu; Oye Gureje; Elie G Karam; Sing Lee; Fernando Navarro-Mateu; Daisuke Nishi; Charlene Rapsey; Kate M Scott; Juan Carlos Stagnaro; Maria Carmen Viana; Bogdan Wojtyniak; Miguel Xavier; Ronald C Kessler Journal: Int J Ment Health Syst Date: 2022-01-29
Authors: Dan J Stein; Alan E Kazdin; Ayelet Meron Ruscio; Wai Tat Chiu; Nancy A Sampson; Hannah N Ziobrowski; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Yasmin Altwaijri; Ronny Bruffaerts; Brendan Bunting; Giovanni de Girolamo; Peter de Jonge; Louisa Degenhardt; Oye Gureje; Josep Maria Haro; Meredith G Harris; Aimee Karam; Elie G Karam; Viviane Kovess-Masfety; Sing Lee; Maria Elena Medina-Mora; Jacek Moskalewicz; Fernando Navarro-Mateu; Daisuke Nishi; José Posada-Villa; Kate M Scott; Maria Carmen Viana; Daniel V Vigo; Miguel Xavier; Zahari Zarkov; Ronald C Kessler Journal: BMC Psychiatry Date: 2021-08-09 Impact factor: 3.630